- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01910857
Improving Hypertension Control
August 24, 2015 updated by: Theodore Kotchen, MD, Medical College of Wisconsin
- The overall hypothesis for the project is that racial health disparities will be reduced by improving hypertension control in African Americans.
- This will be accomplished through the development, implementation, and evaluation of a cost-effective hypertension control strategy based on the involvement of a community health worker.
Study Overview
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 3522
- Lisbon Avenue Health Center
-
Milwaukee, Wisconsin, United States, 53205
- Hillside Family Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- African Americans with uncontrolled hypertension, followed at Progressive Community Health Centers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Standard care
|
|
Experimental: Lifestyle counseling
Lifestyle counseling.
6 group meetings,facilitated by community health worker, focusing on lifestyle change, eg, weight loss, physical activity, low salt, stress reduction
|
weight reduction, low salt, physical activity, stress reduction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in blood pressure (mmHg)
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
December 1, 2013
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
July 23, 2013
First Submitted That Met QC Criteria
July 29, 2013
First Posted (Estimate)
July 30, 2013
Study Record Updates
Last Update Posted (Estimate)
August 26, 2015
Last Update Submitted That Met QC Criteria
August 24, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO16801
- HWPP (Other Grant/Funding Number: 2011D-41)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
Clinical Trials on Lifestyle counseling
-
York UniversityPublic Health Agency of Canada (PHAC)Unknown
-
Case Western Reserve UniversityNational Institutes of Health (NIH); American Heart AssociationCompletedStroke | Multiple Sclerosis | Rheumatoid ArthritisUnited States
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertension | Obesity | Diabetes | Metabolic Syndrome | Hypercholesterolemia
-
Mayo ClinicCompleted
-
UKK InstituteFinnish Institute of Occupational Health; Academy of Finland; Vitalmed Research...CompletedEffects of Weight Reduction on Sleep and Alertness in Long-distance Truck and Bus Drivers (SF-Truck)Abdominal ObesityFinland
-
Federal University of São PauloUnknownPain | Myofascial Pain | Facial Pain | Therapeutic Exercise | Temporomandibular Disorder SyndromeBrazil
-
Maura PalmeryUniversidad Católica San Antonio de Murcia; Research Centre for Food and Nutrition...UnknownMedication AdherenceItaly, Spain
-
The Miriam HospitalCompleted
-
Equipo Multidisciplinar Sanitario CS FoietesCompletedDiabetes Mellitus, Type 2